OpportunityTitle: Increasing the Quality and Efficiency of Clinical Trials (R18)
AdditionalInformationOnEligibility: The following organization is eligible to apply:    Duke Translational Medicine Institute located within Duke University.
Description: The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Medical Policy (OMP) is announcing its intent to accept and consider a single source application for the award of a grant to the Duke University&#146;s Duke Translational Medicine Institute (DTMI) to support increasing the quality and efficiency of clinical trials.
GrantorContactEmailDescription: lisa.ko@fda.hhs.gov
GrantorContactText: Lisa Ko &lt;br/&gt;Grants Management Specialist